AMIODARONE HCL
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
REMEDYREPACK, I
Drug class
Antiarrhythmic - Class III
Class III antiarrhythmics are a functional category of cardiovascular medications defined under the Vaughan Williams classification system. Read more about Antiarrhythmic - Class III
79 drugs in this class 59 manufacturers
Drugs in Antiarrhythmic - Class III
DOFETILIDE
ANTIARRHYTHMIC - CLASS III · CARDIOVERSION OF ATRIAL FIBRILLATION ·+2
GRANULES PHARMA
SOTALOL (sotalol HCl)
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
UNICHEM DBA SAW
SOTALOL AF (sotalol HCl)
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
UNICHEM DBA SAW
AMIODARONE HCL
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
SAFECOR HEALTH
BETAPACE (sotalol HCl)
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
LEGACY PHARMA I
BETAPACE AF (sotalol HCl)
ANTIARRHYTHMIC - CLASS III · LIFE-THREATENING VENTRICULAR TACHYCARDIA ·+2
LEGACY PHARMA I
Filter & compare in the drug finder →
Opens the drug finder with Antiarrhythmic - Class III preselected. Add indication or manufacturer filters there.
Class III antiarrhythmics are a functional category of cardiovascular medications defined under the Vaughan Williams classification system.
These agents work predominantly by blocking cardiac potassium channels, which delays phase 3 repolarization and lengthens both the myocardial action potential duration and the effective refractory period without significantly slowing conduction velocity.
Clinically, they are utilized to terminate and prevent various tachyarrhythmias, most notably atrial fibrillation, atrial flutter, and life-threatening ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation.
Commonly used agents within this therapeutic class include amiodarone, sotalol, dofetilide, and ibutilide.
-
cvpharmacology.com
These agents work predominantly by blocking cardiac potassium channels, which delays phase 3 repolarization and lengthens both the myocardial action potential duration and the effective refractory period without significantly slowing conduction velocity
-
nih.gov
These agents work predominantly by blocking cardiac potassium channels, which delays phase 3 repolarization and lengthens both the myocardial action potential duration and the effective refractory period without significantly slowing conduction velocity
-
nih.gov
Clinically, they are utilized to terminate and prevent various tachyarrhythmias, most notably atrial fibrillation, atrial flutter, and life-threatening ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation
-
nih.gov
Clinically, they are utilized to terminate and prevent various tachyarrhythmias, most notably atrial fibrillation, atrial flutter, and life-threatening ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation
-
nih.gov
Clinically, they are utilized to terminate and prevent various tachyarrhythmias, most notably atrial fibrillation, atrial flutter, and life-threatening ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation
-
amboss.com
Commonly used agents within this therapeutic class include amiodarone, sotalol, dofetilide, and ibutilide
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.